ライフサイエンスコーパス: insulin-sensitizing agent

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 int to evaluate and perhaps develop improved insulin-sensitizing agents.

2 s have demonstrated the potential utility of insulin-sensitizing agents and lipid-lowering therapies

3 estrogen-progestin oral contraceptives, (3) insulin-sensitizing agents, and (4) estrogen-progestin f

4 Newer therapies, such as insulin-sensitizing agents, are beneficial in correcting

5 hese results indicate that treatment with an insulin-sensitizing agent can lead to improvement in bio

6 by thiazolidinediones (TZDs), widely used as insulin-sensitizing agents for the treatment of type 2 d

7 compounds, as well as a subclass of non-TZD insulin-sensitizing agents, have been shown to be peroxi

8 This prospective study evaluates the role of insulin-sensitizing agent in treatment of NASH.

9 primarily focused on weight loss and use of insulin sensitizing agents, including the thiazolidenedi

10 ith hyperinsulinemia and insulin-resistance, insulin-sensitizing agents might be beneficial.

11 h returned to normal upon treatment with the insulin-sensitizing agent pioglitazone.

12 ce all PPARgamma agonists were orally active insulin-sensitizing agents producing reductions of eleva

13 Troglitazone, an insulin sensitizing agent, reduces glucose concentration

14 We additionally hypothesized that an insulin-sensitizing agent (rosiglitazone) would prevent

15 Farglitazar (GI262570), an insulin-sensitizing agent, selectively binds and activat

16 Troglitazone (TRO), a novel insulin-sensitizing agent, significantly lowers blood pr

17 tazone, like other thiazolidinediones, is an insulin-sensitizing agent that activates the peroxisome

18 Rosiglitazone is an insulin-sensitizing agent that has recently been shown t

19 ediones, pioglitazone and rosiglitazone, are insulin sensitizing agents, that are licensed for the ma

20 the intracellular targets of a new class of insulin sensitizing agents, the thiazolidinediones.

21 ance that is distinct from commonly utilized insulin-sensitizing agents, the inhibitor promoted insul

22 A novel class of insulin-sensitizing agents, the thiazolidinedines (TZDs)

23 Novel insulin sensitizing agents, thiazolidinediones, have bee

24 atment of normal (nondiabetic) pigs with the insulin-sensitizing agent troglitazone improves recovery

25 Troglitazone is a new insulin-sensitizing agent used to treat type 2 diabetes

26 is and is the molecular target of a class of insulin-sensitizing agents used for the management of ty

27 iazolidinediones (TZDs) are a novel class of insulin-sensitizing agents used in the treatment of NIDD

28 s and then 4 mg twice daily for 8 weeks), an insulin-sensitizing agent, was given to 7 insulin-resist

29 zone) and troglitazone are thiazolidinedione insulin-sensitizing agents, which are undergoing clinica

30 Metformin is an insulin-sensitizing agent with potent antihyperglycemic

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。